APA (7th ed.) Citation

Vignesh Sivaganesh & Bela Peethambaran. (2023). Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer. Open Exploration Publishing Inc..

Chicago Style (17th ed.) Citation

Vignesh Sivaganesh and Bela Peethambaran. Receptor Tyrosine Kinase-like Orphan Receptor 1 Inhibitor Strictinin Exhibits Anti-cancer Properties Against Highly Aggressive Androgen-independent Prostate Cancer. Open Exploration Publishing Inc., 2023.

MLA (9th ed.) Citation

Vignesh Sivaganesh and Bela Peethambaran. Receptor Tyrosine Kinase-like Orphan Receptor 1 Inhibitor Strictinin Exhibits Anti-cancer Properties Against Highly Aggressive Androgen-independent Prostate Cancer. Open Exploration Publishing Inc., 2023.